Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Imaging outcomes for trials of remyelination in multiple sclerosis.
Treatment of acute transverse myelitis and its early complications.
Rituximab Use in Pediatric Central Demyelinating Disease.
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
Oxidative modification of serum proteins in multiple sclerosis.
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Integrated analysis of daclizumab HYP pharmacokinetics from three phase 1 studies
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.
Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
US court permits generic version of Teva MS drug a year sooner
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
GEMSP: A New Therapeutic Approach to Multiple Sclerosis.
Microglia activation is associated with IFN-α induced depressive-like behavior.
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
Treatment of neuromyelitis optica.
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administration.
Prospective memory, emotional valence, and multiple sclerosis.

Pages